POLLINI, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 559
EU - Europa 556
AS - Asia 244
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.365
Nazione #
US - Stati Uniti d'America 558
CN - Cina 191
GB - Regno Unito 146
IT - Italia 90
IE - Irlanda 78
SE - Svezia 75
FR - Francia 60
DE - Germania 48
FI - Finlandia 26
SG - Singapore 20
TR - Turchia 10
JP - Giappone 9
UA - Ucraina 9
CZ - Repubblica Ceca 7
IN - India 7
NL - Olanda 4
RU - Federazione Russa 3
CL - Cile 2
DK - Danimarca 2
GR - Grecia 2
IL - Israele 2
LU - Lussemburgo 2
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CA - Canada 1
CH - Svizzera 1
EU - Europa 1
HK - Hong Kong 1
KG - Kirghizistan 1
KR - Corea 1
ME - Montenegro 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
Totale 1.365
Città #
Chandler 153
Southend 141
Dublin 78
Beijing 48
Ashburn 47
New York 44
Jacksonville 38
Woodbridge 32
Verona 22
Helsinki 21
Lawrence 17
Princeton 17
Singapore 14
Shenyang 13
Ann Arbor 12
Hebei 12
Houston 12
Jinan 12
Nanjing 12
Wilmington 12
Sindelfingen 9
Tokyo 9
Malatya 8
Redmond 8
Brno 7
Fairfield 7
Bologna 6
Changsha 6
Foresto 6
Haikou 6
Jiaxing 6
Nanchang 6
Fuzhou 5
Guangzhou 5
Hyderabad 5
Seattle 5
Taiyuan 5
Tianjin 5
Cagliari 4
Genova 4
Groenekan 4
Norwalk 4
Bergamo 3
Dongguan 3
Frankfurt am Main 3
Hangzhou 3
Kent 3
Munich 3
Vicenza 3
Washington 3
Zhengzhou 3
Berlin 2
Chicago 2
Falkenstein 2
Ivrea 2
Jerusalem 2
Luxembourg 2
Nesso 2
Ningbo 2
Redwood City 2
Stockholm 2
Taizhou 2
Aigaleo 1
Andover 1
Baku 1
Belluno 1
Bishkek 1
Boardman 1
Cambridge 1
Canberra 1
Central 1
Dallas 1
Iesi 1
Iglesias 1
Islamabad 1
Kyiv 1
Landshut 1
Lappeenranta 1
Las Vegas 1
Leawood 1
Lecce 1
Lima 1
Lisbon 1
London 1
Los Angeles 1
Marburg 1
Montréal 1
Negrar 1
New Delhi 1
Oklahoma City 1
Padova 1
Pauri 1
Podgorica 1
Pozza 1
Reston 1
Riva 1
San Francisco 1
Santiago 1
Seoul 1
Shanghai 1
Totale 974
Nome #
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 114
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 104
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 98
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 96
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 92
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 82
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 81
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 72
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 67
Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery 65
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 64
The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis 63
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 60
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 54
The management of intraductal papillary mucinous neoplasms of the pancreas 53
Serous Cystic Neoplasms of the Pancreas Management in the Real-world: Still Operating on a Benign Entity 50
The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management 37
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 32
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 28
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 23
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 20
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 19
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 18
It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy 13
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation 4
Totale 1.409
Categoria #
all - tutte 5.395
article - articoli 5.395
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020114 9 3 0 6 12 13 9 2 4 13 18 25
2020/2021191 30 18 5 35 20 29 13 3 7 2 11 18
2021/2022139 10 50 0 13 2 2 3 7 5 1 9 37
2022/2023443 21 66 34 72 30 125 12 34 42 0 4 3
2023/2024325 8 26 27 33 44 79 18 13 4 4 56 13
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 1.409